Quartz
중도 성향
IT/기술
Microsoft and Mayo Clinic are teaming up to build a healthcare AI model
Mayo Clinic will own the model, which will be trained on de-identified patient data and initially deployed for use by its clinicians
🇺🇸 미국 · IT/기술 · "CLINIC" · 총 5건
필터 보기현재 지수
50.0
0 = 부정 우세
50 = 중립
100 = 긍정 우세
최근 7일 기준 12,081건을 분석한 결과, 뉴스 심리지수는 50.0(균형)입니다. 긍정 1건(0.0%)·중립 12,079건(100.0%)·부정 1건(0.0%)이며, 중립 비중이 뚜렷하게 높습니다. 성향 지수는 종합 19.2(중도 균형)입니다.
Mayo Clinic will own the model, which will be trained on de-identified patient data and initially deployed for use by its clinicians
At the Cleveland Clinic, some physicians are using ambient AI as part of a push to reduce administrative burden and improve patient experience.
If you’ve ever used an online patient portal to message your doctor in the middle of the night, you won’t be surprised to learn that responding to those messages takes an increasingly big bite out of clinicians’ workdays. So in recent years, hospitals have begun adopting an AI tool that can draft responses for them. […]
Patients who use mobile applications to manage medical conditions including depression and chronic pain might assume the apps have been evaluated by regulatory agencies to be safe and effective. But that isn’t necessarily the case. Most of the more than 55,000 medical apps that claim to diagnose or treat a condition—or ones that provide clinical decision support, known as “therapeutic” apps—have never been assessed by any trusted neutral bodies or regulatory agencies to evaluate them for technical soundness, ethical design, or clinical benefit. The apps often don’t comply with regional data security and privacy laws to protect people’s sensitive health information. Medical apps differ from traditional wellness apps, which provide users with insights into becoming healthier by, for example, tracking fitness activities, monitoring blood pressure, and analyzing sleep patterns. There is no reliable way to verify that therapeutic apps deliver the results they indicate. To help ensure such apps are credible, the IEEE Standards Association (IEEE SA) recently launched the IEEE Global Medical Mobile App Assessment and Registry. The publicly searchable directory is designed to list apps that have been vetted by experts across several criteria including technical soundness, ethical design, compliance with data security and privacy regulations, and clinical efficacy, which is evidence of a clinical benefit for the patient. “Patients, clinicians, payers, and health care systems often struggle to distinguish clinically meaningful therapeutic apps from those that are simply well-marketed,” says IEEE Senior Member Yuri Quintana, chair of the assessment and registry program. He is chief of the clinical informatics division at Beth Israel Deaconess Medical Center, in Boston. “Our goal is to establish a standardized review method using criteria developed by experts.” Why regulation is lacking Because the apps are intended for medical use without being part of a medical implement, they fall under the designation of software as a medical device (SaMD), according to the International Medical Device Regulators Forum. SaMD is supposed to be regulated by public health agencies such as the U.S. Food and Drug Administration, but the apps have developed and grown in popularity so quickly that regulators haven’t been able to keep up, Quintana says. Some companies have received approval, but most have not, he says. Many users are unaware of the regulatory gap, he says. “Seeing an app from a well-known company often creates the impression that it has been meaningfully vetted for safety and efficacy, even when that is not the case,” he says. Some companies are using deceptive advertising to sell their product, he adds. Marketing materials might claim that all of a company’s health apps are certified, even though only one app has been approved by a regulatory body to treat a particular condition. Or the verbiage might imply the company has clinical evidence proving its application works, even though the app has never been tested independently. Another concern is that updated apps aren’t being vetted, says Maria Palombini, IEEE SA’s director of health care and life sciences global practice lead. “The original app might have received approval from a regulatory agency, but not the updated version,” Palombini says. “There could have been significant changes from the original.” “Not every medical-related app triggers the same regulatory classification or review across jurisdictions,” Quintana adds. “That leaves a large gray zone of clinically relevant but lower-risk apps that haven’t undergone an independent assessment. The IEEE registry was created to help fill these gaps. “IEEE is the best organization to address this problem because this is fundamentally a standards, trust, interoperability, and conformity assessment challenge,” he says. IEEE “is the world’s largest technical professional organization, with deep expertise in developing globally recognized standards including in health care, cybersecurity, AI ethics, and interoperability.” “Through the IEEE Conformity Assessment Program, we already run rigorous assessment and registry programs,” Palombini says. “Our neutral, consensus-driven, multidisciplinary approach—bringing together clinicians, regulators, developers, and ethicists without commercial bias—makes IEEE uniquely positioned to create trustworthy global guardrails that can scale across jurisdictions and support regulatory harmonization.” How the registry works The assessment framework was developed by a multidisciplinary group of 35 volunteer experts from 10 countries, Quintana says. The panel includes academics, AI experts, app developers, clinicians, ethicists, mental health experts, patient advocates, regulators, researchers, technologists, and those who assess safety in health care. The registry is for any app used for clinical care or therapeutics that claims to demonstrate a medical benefit. That includes apps designed for cardiology, diabetes, mental health, neurology, oncology, rehabilitation, and respiratory diseases, Quintana says. Initially, he says, the focus will be on apps that aim to treat mental health conditions, given the large number of offerings in that area and the registry committee’s expertise. The submission of apps is voluntary. There is no government mandate that requires a company to use the IEEE registry. The products will be evaluated against about 150 consensus-based criteria across three major areas: Clinical efficacy including therapeutic effectiveness, any sustained benefits, risk management, comparison to standard care, user engagement, and real clinical value. Technical soundness including accessibility, privacy and security, error handling, interoperability, AI governance, usability, and operational quality. Ethical design including bias prevention, patient consent, data governance, conflict-of-interest transparency, responsible use of AI and large language models, and prioritization of public health benefits. IEEE charges a nonrefundable submission fee that covers the cost of the assessment plus the registry’s annual subscription for the first year. Developers first must demonstrate they are a legally established entity before they can complete the app publisher registration form and then submit documentation and attestations about the product. The IEEE review of an app is estimated to take six to eight weeks, Palombini says. The assessment results will be privately shared with the app publisher, she says, and to be listed in the registry, an app must achieve more than 85 percent compliance in each category. Upgraded apps must be submitted and reassessed, Palombini says. Similar to how users are notified when an app on their smart devices has , the registry will be notified when listed apps have a new update available, she says. Applicants who do not pass the assessment are to receive feedback explaining why. They will be given an opportunity to make changes or provide additional documentation, Palombini says. “It’s a pretty methodological process, with checks and balances,” Quintana says. “We’re being very transparent about the process.” Approved apps added to the registry receive an IEEE certification badge and submission identifier, which the company can display on its website, app store listings, and marketing materials. “The badge serves as visible proof that the app has met the independent, consensus-based assessment for clinical value, technical robustness, and ethical design,” Quintana says. The registry will be publicly available at no cost, he says. Patients and families seeking safe, trustworthy apps—and payers and insurers evaluating reimbursement potential—will find the registry helpful, he says. The application website is open. The public registry page does not yet list a specific count of approved apps because assessments are ongoing. Approved apps and their unique identifiers are to be published when the initial reviews are completed. To learn more, you can watch a webinar recorded in March. The assessment framework that underpins the registry is supporting the formal recognition of IEEE P3962 Standard for Criteria Assessment Framework f
This sponsored article is brought to you by Melbourne Convention Bureau (MCB) supported by Business Events Australia. Melbourne’s reputation as a global events city, from the Australian Open tennis and Formula 1 Australian Grand Prix to hosting NFL regular season games, now intersects with a different form of scale: large-scale compute, data-intensive research, and advanced engineering. Long recognized for delivering complex international events, the city is applying the same organisational capability to the infrastructure that underpins modern AI research, positioning Melbourne at the convergence of global convening and high-performance digital systems. Consistently ranked among the world’s most livable cities, Melbourne was named Time Out’s Best City in the World in 2026, the first Australian city to hold the title. Melbourne, Australia’s premier conference destination. Tourism Australia More materially for research and innovation, Melbourne is also the nation’s fastest‑growing capital, attracting increasing concentrations of engineering and technology talent, investment and international engagement. Australia’s artificial intelligence (AI) ecosystem is entering a new phase, defined less by isolated initiatives and more by the convergence of compute infrastructure, research intensity and international collaboration. Melbourne sits at this intersection. Melbourne’s trajectory highlights what enables research at scale: access to frontier-grade compute, proximity to industry-ready infrastructure, and repeated opportunities for global research communities to convene. Sovereign AI compute, expanding hyperscale data center campuses and a growing pipeline of international research-led conferences are reshaping the city’s research landscape. Together, these elements position Melbourne as a focal point for applied AI research, advanced engineering and data-intensive science. The growing global influence of AI engineering, underscored by NVIDIA CEO Jensen Huang receiving the 2026 IEEE Medal of Honor, reflects the scale of this shift. In Melbourne, these factors form a reinforcing research flywheel linking infrastructure, discovery and collaboration. Rather than focusing on startup density or short-term commercial output, Melbourne’s trajectory highlights what enables research at scale: access to frontier-grade compute, proximity to industry-ready infrastructure, and repeated opportunities for global research communities to convene. NVIDIA CEO Jensen Huang received the 2026 IEEE Medal of Honor.IEEE Sovereign AI foundations The most recent cornerstone of Melbourne’s AI capability is MAVERIC (Monash AdVanced Environment for Research and Intelligent Computing), Australia’s largest university-based AI supercomputer. Built and deployed by Monash University in partnership with NVIDIA, Dell Technologies, and CDC Data Centres, MAVERIC has been engineered specifically for large scale AI and data intensive science, with medical research representing a key priority. Indeed, in these regards MAVERIC has been designed to function as a Next Generation Trusted Research Environment thus ensuring that it is state-of-the-art and provides a safe and secure framework for the analysis of large sensitive datasets. Designed to support research projects including cancer and neurodegenerative disease detection, clinical trial analysis and drug discovery through to materials science and engineering, MAVERIC enables Australian researchers to train and evaluate large models domestically while keeping highly sensitive datasets secure and under national jurisdiction. This sovereign design is particularly relevant in fields such as medical research where privacy, regulation or intellectual property constraints limit the use of offshore cloud resources. Monash University Vice-Chancellor and President Professor Sharon Pickering with researchers [left to right] Professor Anton Peleg, Professor Victoria Mar, Professor James Whisstock, Vice-President (Strategy and Major Projects) Teresa Finlayson, and Professor Patrick Kwan.Eamon Gallagher (Australian Financial Review) Technically, the system reflects the latest shifts in high performance AI architecture. Built on NVIDIA GB200 NVL72 platforms and integrated using Dell’s rack scale infrastructure, MAVERIC employs closed loop liquid cooling to reduce water consumption compared with conventional air-cooled systems, aligning large scale compute growth with sustainability objectives while supporting high density, high throughput workloads. Professor James Whisstock, Deputy Dean Research of Monash’s Faculty of Medicine, Nursing, and Health Sciences commented, “MAVERIC provides a huge leap forward in our compute capability that will revolutionize our researchers’ ability to address the most challenging and important research questions across the fields of medical research, information technology, and STEM disciplines. It will seed wonderful new cross-disciplinary collaborations, underpin the work of our best and brightest young researchers and will allow our scientists to continue to make major discoveries that positively impact the Australian and global population more broadly.” “MAVERIC provides a huge leap forward in our compute capability that will revolutionize our researchers’ ability to address the most challenging and important research questions across the fields of medical research, information technology, and STEM disciplines.” —Professor James Whisstock, Deputy Dean Research of Monash’s Faculty of Medicine, Nursing, and Health Sciences Monash University frames MAVERIC not as a standalone asset, but as part of the national research infrastructure, intended to strengthen collaboration across academia, healthcare, government and industry. This approach positions Melbourne at the forefront of sovereign AI enabled research in the region. Data center scale as research infrastructure The infrastructure demands of modern AI research extend well beyond individual systems. Melbourne’s expanding data center footprint now supports hyperscale compute, applied AI deployment and large-scale research workloads simultaneously. Total data center investment, US$ billions.Source: Data Centres Global Report 2025 In February 2026, CDC Data Centres opened its first Melbourne campus in Brooklyn, with two live facilities and a third in planning. Combined with CDC’s Laverton campus, Melbourne is projected to host more than 800 megawatts of sovereign digital capacity, critical for AI workloads requiring sustained access to high-density power, cooling and secure environments. Parallel investment is underway in Fishermans Bend, where NEXTDC is developing a AUD $2 billion AI and digital infrastructure hub adjacent to the Innovation Precinct. Planned facilities include an AI Factory, a Mission Critical Operations Center and a Technology Center of Excellence, enabling sovereign AI, high-performance computing and cross-sector collaboration across health, defence and finance. Melbourne hosts Australia’s largest cluster of AI firms, with 188 companies, and more than 40 data centers currently operate across Victoria. The Victorian Government has complemented this growth with an initial AUD $5.5 million investment in the Sustainable Data Center Action Plan. Together, these developments reinforce Melbourne’s role as a national and increasingly global hub for high-performance AI infrastructure as model complexity and infrastructure dependency continue to accelerate. Applied AI research at scale Monash University is home to MAVERIC, Australia’s largest university-based AI supercomputer, built and deployed by Monash in partnership with NVIDIA, Dell Technologies, and CDC Data Centres.Monash University Melbourne’s research strength is underpinned by a dense university network with deep capability across AI, data science and engineering. Institutions including Monash University, the University of Melbourne, Deakin University, La Trobe University, RMIT University and Swinburne University of Technology collectively support research across machine learning, robotics, human-computer interaction, extended reality and advanced manufacturing. This concentration fosters applied collaboration where AI intersects with medicine, sustainability, cognitive systems and immersive technologies. For visiting researchers, it provides access not only to academic expertise but also to live infrastructure environments where research can be tested and validated, reinforcing Melbourne’s position as one of the Asia-Pacific’s most integrated AI research ecosystems. Conferences as research accelerators Plenary session at Melbourne Convention and Exhibition Center.Melbourne Convention Bureau Melbourne’s selection as host city for a growing number of international technology conferences reflects the convergence of research capability and infrastructure maturity. In September 2026, Data Center World Australia and The AI Summit Australia will be co-located at the Melbourne Convention and Exhibition Center, bringing together global leaders across AI, digital infrastructure and enterprise technology. The pairing highlights a broader reality: advances in AI are inseparable from the infrastructure that enables them. Melbourne’s expanding data center footprint now supports hyperscale compute, applied AI deployment and large-scale research workloads simultaneously. Research-led conferences are also expanding Melbourne’s global footprint. ICONIP 2026, hosted by Deakin University, will bring up to 700 researchers in neural networks and machine learning, followed in 2027 by IEEE VR, the leading conference on virtual reality and 3D user interfaces, attracting up to 1,000 delegates. In this context, conferences function not simply as events, but as infrastructure for knowledge transfer, supporting standards exchange, collaboration and system-level learning at global scale. A global platform for advancing research Sovereign compute, data center scale and a strong conference pipeline create a reinforcing cycle, enabling researchers to engage directly with infrastructure and industry well beyond the event itself. By closing the gap between theory and deployment, Melbourne supports deeper technical exchange and more enduring global research networks. This role was recognized in 2025 when the IEEE awarded Melbourne Convention Bureau the 2025 Organisational Supporting Friend of IEEE Member and Geographic Activities (MGA) — the first convention bureau in the Asia Pacific region to receive the acknowledgement as a result of the longstanding partnership with the IEEE Victorian Section. Melbourne Convention Bureau (MCB) representative Fatima Aboudrar, Senior Business Development Manager, with Vijay S. Paul, Immediate Past Chair, IEEE Victorian Section, receiving Supporting Friend Member recognition in 2025. As AI research becomes increasingly dependent on infrastructure scale, sovereign capability, and global collaboration, Melbourne is moving beyond hosting conversations to actively enabling the systems that advance AI and data‑driven research at global scale. Conference support in Melbourne Your browser does not support the video tag. Why host a conference in Melbourne, Australia.Melbourne Convention Bureau This ecosystem is underpinned by Melbourne’s highly accessible city center, where world-class venues, research institutions and industry hubs are located in close proximity. Free public transport and a compact city footprint enable seamless movement from conference floor to real-world application. Melbourne Convention Bureau (MCB) is a not-for-profit state government agency with over 60 years’ experience, that provides IEEE and its members with free support to bring international conferences to Melbourne, Australia. MCB’s support spans early-stage exploration and international bidding through to securing government funding, connecting organizers with venues, accommodation and event suppliers, and providing destination support for conference planning and delivery. Organizations considering a conference in Australia are encouraged to connect with MCB’s dedicated team, which supports IEEE conferences in Melbourne. Enquiries can be directed to info@melbournecb.com.au.